Podcasts about pediatric

Why do some pediatric practices become local favorites while others fade into the background?In this episode, Michael delves into the psychology of ground marketing tailored for pediatric dental practices, revealing why trust is the foundation for building lasting relationships with local families. He unpacks the dual priorities facing dentists: winning over discerning parents with micro trust-building moments, while making sure kids feel safe and comfortable from the first hello. Through real-world stories and tested tactics, you'll discover how influencing word-of-mouth and creating educational opportunities puts your practice in the conversation of every parent group.Michael doesn't stop at the basics—he explores actionable strategies you can launch tomorrow for deep community engagement. Learn how partnerships with daycare centers and schools, creative health talks, and unique events like hidden book treasure hunts or teacher recharge stations set your practice apart. He also gives you the operational playbook: capturing valuable data at every touchpoint, deploying targeted follow-up, and transforming positive community impressions into appointments. By the end, you'll have a blueprint to elevate your in-office experience, ensuring your ground marketing efforts translate into ongoing loyalty and genuine patient trust.What You'll Learn in This Episode:How to build trust with both parents and children in pediatric settingsEffective word-of-mouth marketing techniques for local influenceCommunity partnership ideas with schools, libraries, activity centers, and pediatriciansCreative in-person events to educate and engage familiesUnique reciprocity strategies, like mouth guard scholarships and recharge stationsBest practices for gathering and using data at eventsRobust follow-up systems to convert leads into actual appointmentsDifferentiating your in-office experience to reinforce marketing gainsOperational tactics for maximizing your ROI on ground marketingThe must-have steps for tracking, measuring, and optimizing each outreachJump in now to discover how your pediatric practice can become the go-to spot for families in your community!‍‍Learn More About the Ground Marketing Course Here:Website: thedentalmarketer.lpages.co/the-ground-marketing-course-open-enrollment‍The Pediatric Dental Marketing Course is open for enrollment!Head over to our site to enroll now! pediatricdentalmarketingcourse.com‍Host: Michael AriasJoin my newsletter: https://thedentalmarketer.lpages.co/newsletter/‍Join this podcast's Facebook Group: The Dental Marketer Society‍Love the Podcast? Let Us Know How We're Doing on Apple Podcasts!

You know those cases where things just don't add up? In this episode, we break down a pediatric respiratory case that started out like routine asthma, but something didn't sit right. Tune in as we walk through the red flags, physical exam clues, and how one small detail changed everything. Perfect for nurse practitioners looking to sharpen their clinical reasoning and differential diagnosis in pediatric primary care.Check out Picmonic: https://www.picmonic.comCheck out our eBooks designed specifically for NP students navigating the clinical setting!⁠⁠⁠ ⁠⁠⁠⁠⁠https://bit.ly/SuccessNPebook⁠⁠⁠⁠Follow us on instagram:⁠ ⁠⁠ ⁠@thesuccesnp⁠⁠⁠⁠Go to our website⁠ ⁠⁠www.successnps.com⁠⁠

In this episode we'll share tips and tricks to win over the pediatric patient. We'll be joined by an expert in the field—Dr. Julia Richman, a board-certified pediatric dentist with years of clinical experience and a passion for helping both kids and clinicians feel more confident in the operatory.

Link for CME Credit Coming Soon! In this episode of Pediatrics Now, host and executive producer Holly Wayment welcomes back Dr. Ted Wu to explore the critical topic of sepsis in children. Dr. Wu, with 19 years of experience in pediatric critical care, discusses the intricacies of diagnosing and managing sepsis in neonates and infants, emphasizing the importance of early recognition and tailored treatment strategies. The episode delves into the latest research coming out of Cincinnati Children's Hospital, revealing groundbreaking techniques such as JEDI, which helps categorize sepsis patients based on genetic markers for more individualized care. Holly and Dr. Wu also touch upon real-life implications in pediatric practice, sharing essential warning signs of sepsis, particularly in viral seasons, and how general pediatricians can make critical interventions in the first hour of diagnosis. Listeners will gain valuable insights into the evolving landscape of sepsis treatment, including the role of antibiotics, fluid management, and the complex decisions pediatric practitioners face in urgent care settings. Tune in for a comprehensive discussion that balances medical knowledge with practical, on-the-ground advice for those encountering this life-threatening condition.

In this episode of the Tick Boot Camp Podcast, we sit down with Dr. Tracey Gaslin, a dual-certified Pediatric and Family Nurse Practitioner and the CEO of the Alliance for Camp Health (ACH). Dr. Gaslin leads the Fight the Bite initiative, a national campaign designed to prevent Lyme and other tick-borne illnesses through science-based public health education. She discusses how camps—often overlooked as public health allies—can play a critical role in early detection, prevention, and education for tick-borne disease. With over 3,500 staff trained and 25,000 kids protected, this conversation is packed with insights and action steps for caregivers, clinicians, and camp professionals alike.

This week we review a recent surgical paper on the 'off-label' use of the Melody valve for replacement of the AV valve in small infants and children. How effective and safe was this procedure? What factors were associated with the need for reintervention and what sorts of reinterventions were most common? Why was catheter based reintervention rarely employed? What sort of anti-coagulation protocol seems best to protect these valves? Assistant Professor of Pediatrics at the University of Nebraska, Dr. Samantha Gilg shares the insights from her work this week. DOI: 10.1007/s00246-024-03538-1

In this episode of the Inside EMS podcast, Chris Cebollero and Kelly Grayson tackle one of the most nerve-wracking scenarios in EMS: the pediatric respiratory emergency. From the moment you see a gasping toddler in mom's arms, you know this is a make-or-break call — and for many providers, it's the one that keeps them up at night. Chris kicks things off with a haunting real-life scenario that sets the stage for an in-depth conversation on how to recognize and respond to pediatric respiratory distress. Kelly, a seasoned PALS instructor with a knack for demystifying pediatrics, offers practical advice on assessing sick kids using tools like the Pediatric Assessment Triangle, reading subtle signs like head bobbing or limp limbs, and why the good ol' basics — like BVM ventilation and suction — save lives. From clinical pearls to mindset resets, this episode is a must-listen if you want to face your pediatric fears and come out stronger. Memorable quotes “If we know that's a weakness for our employees, what are we doing to help them make it a strength?” “You bring calm to the chaos. You bring presence to the panic. You bring hope to the people who are living their worst moment.” “This is not about just about a clinical challenge; but it's a fear of getting something wrong.” Enjoying the show? Email theshow@ems1.com to share your feedback. 

Listen here for your audio sneak peek of the May/June issue of Pediatric Nursing! For over 50 years, Pediatric Nursing has been the trusted resource for advancing evidence-based practice, clinical research, and professional development in pediatric nursing.With 2.5 NCPD contact hours available, this issue is packed with opportunities to advance your practice and deliver exceptional care to pediatric patients.Visit www.pediatricnursing.net to subscribe or access individual articles. Don't forget to follow us on social media for more updates!© Jannetti Publications, Inc.All rights reserved. No portion of this podcast may be used without written permission.To learn more about Pediatric Nursing and subscribe, visit www.pediatricnursing.net.Music by Scott Holmes.http://www.scottholmesmusic.com

In the latest episode of Surgical Readings from SRGS, host Rick Greene, MD, FACS, is joined by Associate Editors Carmelle Romain, MD, FACS, and Manish Raiji, MD, FACS, from the University of Chicago's Department of Surgery. Together, they explore key topics in pediatric surgical care, including necrotizing enterocolitis, intestinal obstruction, pediatric trauma resuscitation, and more. Learn more about Selected Readings in General Surgery, an American College of Surgeons publication that highlights highly relevant and practice-changing information from the world's most prominent medical journals. #SurgicalReadings #SRGS

Guided by the tenets of Kolcaba's holistic comfort theory, Dr. April Braswell explains how they developed, implemented, and evaluated a simulated online pediatric advanced practice health center. The Pediatric Comfy Care Clinic (PCCC) was created to enhance person-centered diagnostic reasoning and holistic advanced management skills for family nurse practitioner students. Learn more about the PCCC in their article.

Months after 11-year old Brayden Robbins died while seeking emergency care, his family is renewing calls for drastic improvements to the health-care system, especially pediatric care. B.C. Health Minister Josie Osborne joins the show to respond to the calls.Conservative rural health critic Brennan Day wrote a letter to Osborne with recommendations to improve care in response to Brayden's death. He joins the show as we ask viewers about their experiences seeking emergency care.

With the Wind with Dr. Paul – Show 179 Pediatric Perspectives: What Has Changed with Cancer, with William Makis, M.D. ________________________________________ Title: What Has Changed with Cancer? Presenters: Dr. Paul Thomas, William Makis, M.D. Length: Approximately 40 minutes ________________________________________ Web Resources Discussed: • Dr. William Makis MD | Substack: https://substack.com/@makismd • The Wellness Company | William Makis, M.D.: https://www.twc.health/pages/dr-william-makis • With the Wind: SCIENCE Revealed; with Paul Thomas MD: https://www.doctorsandscience.com/ • Kids First 4 Ever: https://www.kidsfirst4ever.com/#/ ________________________________________ Key Points (with approximate timestamps): • 00:00:00 – Dr. Paul opens with a sobering introduction to the episode's theme: why cancer is behaving differently in the post-COVID era. • 00:02:30 – Dr. Makis introduces the concept of “turbo cancers” — aggressive, rapidly progressing cancers seen since the COVID vaccine rollout. • 00:08:45 – They discuss how traditional oncology has not evolved and the failures of chemotherapy and radiation to improve survival in many cancer types. • 00:15:20 – Dr. Makis details the explosion in cancers among young, previously healthy individuals, especially athletes, and post-COVID vaccine recipients. • 00:22:10 – Discussion shifts to the roles of mRNA, LNPs, and spike proteins in immune dysfunction and cancer progression. • 00:29:50 – Dr. Makis calls out systemic censorship in Canada and the medical establishment's refusal to investigate vaccine-related cancer trends. • 00:34:00 – Closing thoughts from both doctors urging viewers to stay informed, demand transparency, and resist medical coercion. ________________________________________ Summary: In this compelling and controversial episode, Dr. Paul Thomas is joined by Dr. William Makis to explore the unprecedented surge in aggressive cancers since the global adoption of COVID-19 vaccines. Dr. Makis, a radiologist and oncologist with a deep background in both cancer imaging and treatment, offers evidence of alarming changes in cancer rates, especially among the young and previously healthy. The pair explore potential links to immune dysregulation, spike protein exposure, and gene therapy-based injections. This episode dives into the data, the medical silence, and the urgent need for open dialogue and alternative therapies. ________________________________________ Conclusion: This episode is a must-wat

Screening has moved front and center in the conversation around type 1 diabetes. But we're just at the very beginning of this – what do we really need to know? I'm talking to Dr. Shara Bialo – she's a pediatric endocrinologist who lives with type 1. She was diagnosed as a kid while in DKA. She's working with Sanofi to push for screening, but this is personal – we talk about wanting better guidelines, and more mental health support. And how do we move this research into the general population, where it can have the greatest impact? More about screening here  This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Previous episodes with Ben Mar here Join us at an upcoming Moms' Night Out event! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Eric Topol (00:05):Hello, it's Eric Topol from Ground Truths, and I've got some really exciting stuff to talk to you about today. And it's about the announcement for a new Center for pediatric CRISPR Cures. And I'm delight to introduce doctors Jennifer Doudna and Priscilla Chan. And so, first let me say this is amazing to see this thing going forward. It's an outgrowth of a New England Journal paper and monumental report on CRISPR in May. [See the below post for more context]Let me introduce first, Dr. Doudna. Jennifer is the Li Ka Shing Chancellor's Chair and a Professor in the departments of chemistry and of molecular and cell biology at the University of California Berkeley. She's also the subject of this book, one of my favorite books of all time, the Code Breaker. And as you know, the 2020 Nobel Prize laureate for her work in CRISPR-Cas9 genome editing, and she founded the Innovative Genomics Institute (IGI) back 10 years ago. So Jennifer, welcome.Jennifer Doudna (01:08):Thank you, Eric. Great to be here.Eric Topol (01:10):And now Dr. Priscilla Chan, who is the co-founder of the Chan Zuckerberg Initiative (CZI) that also was started back in 2015. So here we are, a decade later, these two leaders. She is a pediatrician having trained at UCSF and is committed to the initiative which has as its mission statement, “to make it possible to cure, prevent, and manage all diseases in this century.” So today we're going to talk about a step closer to that. Welcome, Priscilla.Priscilla Chan (01:44):Thank you. Thanks for having me.Eric Topol (01:46):Alright, so I thought we'd start off by, how did you two get together? Have you known each other for over this past decade since you both got all your things going?Jennifer Doudna (01:56):Yes, we have. We've known each other for a while. And of course, I've admired the progress at the CZI on fundamental science. I was an advisor very early on and I think actually that's how we got to know each other. Right, Priscilla?Priscilla Chan (02:11):Yeah, that's right. We got to know each other then. And we've been crisscrossing paths. And I personally remember the day you won the Nobel Prize. It was in the heart of the pandemic and a lot of celebrations were happening over Zoom. And I grabbed my then 5-year-old and got onto the UCSF celebration and I was like, look, this is happening. And it was really cool for me and for my daughter.Eric Topol (02:46):Well, it's pretty remarkable convergence leading up to today's announcement, but I know Priscilla, that you've been active in this rare disease space, you've had at CZI a Rare As One Project. Maybe you could tell us a bit about that.Priscilla Chan (03:01):Yeah, so at CZI, we work on basic science research, and I think that often surprises people because they know that I'm a pediatrician. And so, they often think, oh, you must work in healthcare or healthcare delivery. And we've actually chosen very intentionally to work in basic science research. In part because my training as a pediatrician at UCSF. As you both know, UCSF is a tertiary coronary care center where we see very unusual and rare cases of pediatric presentations. And it was there where I learned how little we knew about rare diseases and diseases in general and how powerful patients were. And that research was the pipeline for hope and for new discoveries for these families that often otherwise don't have very much access to treatments or cures. They have a PDF that maybe describes what their child has. And so, I decided to invest in basic science through CZI, but always saw the power of bringing rare disease patient cohorts. One, because if you've ever met a parent of a child with rare disease, they are a force to be reckoned with. Two, they can make research so much better due to their insights as patients and patient advocates. And I think they close the distance between basic science and impact in patients. And so, we've been working on that since 2019 and has been a passion of ours.Eric Topol (04:40):Wow, that's great. Now Jennifer, this IGI that you founded a decade ago, it's doing all kinds of things that are even well beyond rare diseases. We recently spoke, I know on Ground Truths about things as diverse as editing the gut microbiome in asthma and potentially someday Alzheimer's. But here you were very much involved at IGI with the baby KJ Muldoon. Maybe you could take us through this because this is such an extraordinary advance in the whole CRISPR Cures story.Jennifer Doudna (05:18):Yes, Eric. It's a very exciting story and we're very, very proud of the teamwork that went into making it possible to cure baby KJ of his very rare disease. And in brief, the story began back in August of last year when he was born with a metabolic disorder that prevented him from digesting protein, it's called a urea cycle disorder and rare, but extremely severe. And to the point where he was in the ICU and facing a very, very difficult prognosis. And so, fortunately his clinical team at Children's Hospital of Philadelphia (CHOP) reached out to Fyodor Urnov, who is the Director of Translational Medicine at the IGI here in the Bay Area. They teamed up and realized that they could quickly diagnose that child because we had an IRB approved here at the IGI that allowed us to collect patient samples and do diagnosis. So that was done.Jennifer Doudna (06:26):We created an off-the-shelf CRISPR therapy that would be targeted to the exact mutation that caused that young boy's disease. And then we worked with the FDA in Washington to make sure that we could very safely proceed with testing of that therapy initially in the lab and then ultimately in two different animal models. And then we opened a clinical trial that allowed that boy to be enrolled with, of course his parents' approval and for him to be dosed and the result was spectacular. And in fact, he was released from the hospital recently as a happy, healthy child, gaining lots of weight and looking very chunky. So it's really exciting.Eric Topol (07:16):It's so amazing. I don't think people necessarily grasp this. This timeline [see above] that we'll post with this is just mind boggling how you could, as you said Jennifer, in about six months to go from the birth and sequencing through cell specific cultures with the genome mutations through multiple experimental models with non-human primates even, looking at off-target effects, through the multiple FDA reviews and then dosing, cumulatively three dosing to save this baby's life. It really just amazing. Now that is a template. And before we go to this new Center, I just wanted to also mention not just the timeline of compression, which is unimaginable and the partnership that you've had at IGI with I guess Danaher to help manufacture, which is just another part of the story. But also the fact that you're not just even with CRISPR 1.0 as being used in approvals previously for sickle cell and β-thalassemia, but now we're talking about base editing in vivo in the body using mRNA delivery. So maybe you could comment on that, Jennifer.Jennifer Doudna (08:38):Yeah, very good point. So yeah, we used a version of CRISPR that was created by David Liu at the Broad Institute and published and available. And so, it was possible to create that, again, targeted to the exact mutation that caused baby KJ's disease. And fortunately, there was also an off-the-shelf way to deliver it because we had access to lipid nanoparticles that were developed for other purposes including vaccinations. And the type of disease that KJ suffered from is one that is treatable by editing cells in the liver, which is where the lipid nanoparticle naturally goes. So there were definitely some serendipity here, but it was amazing how all of these pieces were available. We just had to pull them together to create this therapy.Eric Topol (09:30):Yeah, no, it is amazing. So that I think is a great substrate for starting a new Center. And so, maybe back to you Priscilla, as to what your vision was when working with Jennifer and IGI to go through with this.Priscilla Chan (09:45):I think the thing that's incredibly exciting, you mentioned that at CZI our mission is to cure, prevent, and manage all disease. And when we talked about this 10 years ago, it felt like this far off idea, but every day it seems closer and closer. And I think the part that's super exciting about this is the direct connection between the basic science that's happening in CRISPR and the molecular and down to the nucleotide understanding of these mutations and the ability to correct them. And I think many of us, our imaginations have included this possibility, but it's very exciting that it has happened with baby KJ and CHOP. And we need to be able to do the work to understand how we can treat more patients this way, how to understand the obstacles, unblock them, streamline the process, bring down the cost, so that we better understand this pathway for treatment, as well as to increasingly democratize access to this type of platform. And so, our hope is to be able to do that. Take the work and inspiration that IGI and the team at CHOP have done and continue to push forward and to look at more cases, look at more organ systems. We're going to be looking in addition to the liver, at the bone marrow and the immune system.Priscilla Chan (11:17):And to be able to really work through more of the steps so that we can bring this to more families and patients.Eric Topol (11:30):Yeah, well it's pretty remarkable because here you have incurable ultra-rare diseases. If you can help these babies, just think of what this could do in a much broader context. I mean there a lot of common diseases have their roots with some of these very rare ones. So how do you see going forward, Jennifer, as to where you UC Berkeley, Gladstone, UCSF. I'm envious of you all up there in Northern California I have to say, will pull this off. How will you get the first similar case to KJ Muldoon going forward?Jennifer Doudna (12:13):Right. Well, IGI is a joint institute, as you probably know, Eric. So we were founded 10 years ago as a joint institute between UC Berkeley and UCSF. And now we have a third campus partner, UC Davis and we have the Gladstone Institute. So we've got an extraordinary group of clinicians and researchers that are coming together for this project and the Center to make it a success. We are building a clinical team at UCSF. We have several extraordinary leaders including Jennifer Puck and Chris Dvorak, and they are both going to be involved in identifying patients that could be enrolled in this program based on their diagnosis. And we will have a clinical advisory group that will help with that as well. So we'll be vetting patients probably right after we announce this, we're going to be looking to start enrolling people who might need this type of help.Eric Topol (13:18):Do you think it's possible to go any faster right now than the six months that it took for KJ?Jennifer Doudna (13:26):I think it could be. And here's the reason. There's a very interesting possibility that because of the type of technology that we're talking about with CRISPR, which fundamentally, and you and I have talked about this previously on your other podcast. But we've talked about the fact that it's a programmable technology and that means that we can change one aspect of it, one piece of it, which is a piece of a molecule called RNA that's able to direct CRISPR to the right sequence where we want to do editing and not change anything else about it. The protein, the CRISPR protein stays the same, the delivery vehicle stays the same, everything else stays the same. And so, we're working right now with FDA to get a platform designation for CRISPR that might allow streamlining of the testing process in some cases. So it'll obviously come down to the details of the disease, but we're hopeful that in the end it will be possible. And Priscilla and I have talked about this too, that as AI continues to advance and we get more and more information about rare diseases, we'll be able to predict accurately the effects of editing. And so, in some cases in the future it may be possible to streamline the testing process even further safely.Eric Topol (14:51):And I also would note, as you both know, well this administration is really keen on genome editing and they've had a joint announcement regarding their support. And in my discussions with the FDA commissioner, this is something they are very excited about. So the timing of the new Center for pediatric CRISPR Cures is aligned with the current administration, which is good to see. It's not always the case. Now going back, Priscilla, to your point that not just for the liver because delivery has been an issue of course, and we're going to try to get after a lot of these really rare diseases, it's going to go beyond there. So this is also an exciting new dimension of the Center, as you said, to go after the bone marrow for hematopoietic cells, perhaps other organs as well.Priscilla Chan (15:42):I mean what the expertise and feasibility, the immune system is going to be the next target. Jennifer Puck has been a pioneer in this work. She's the one who designed the newborn screen that will be the tool that picks up these patients as they are born. And I think the thing that's tremendous is the immune system, first of all is active in many, many diseases, not just these cases of children born with partial or absence of immune systems. And the course right now that these babies are left with is complete isolation and then a very long and arduous course of a bone marrow transplant with high morbidity and mortality. And even if after the transplant you have complications like graft versus host and immunosuppression. And so, the idea of being able to very specifically and with less the conditioning and morbidity and mortality of the treatment, being able to address this is incredible. And the implications for other diseases like blood cancers or other hematopoietic diseases, that's incredible. And that actually has an incredibly broad base of patients that can benefit from the learnings from these babies with severe combined immunodeficiencies.Eric Topol (17:10):Yeah, I think that goes back to a point earlier maybe to amplify in that previous CRISPR generation, it required outside the body work and it was extremely laborious and time consuming and obviously added much more to the expense because of hospitalization time. This is different. This is basically doing this inside the affected patient's body. And that is one of the biggest reasons why this is a big step forward and why we're so fortunate that your Center is moving forward. Maybe before we wrap up, you might want to comment, Jennifer on how you were able to bring in to build this platform, the manufacturing arm of it, because that seems to be yet another dimension that's helpful.Jennifer Doudna (18:01):Indeed, yes. And we were again fortunate with timing because you mentioned briefly that the IGI had set up a program with the Danaher Corporation back in January of last year. We call it our Beacon project. And it's focused on rare disease. And it's a really interesting kind of a unique partnership because Danaher is a manufacturing conglomerate. So they have companies that make molecules, they make proteins, they make RNA molecules, they make delivery molecules. And so, they were excited to be involved with us because they want to be a provider of these types of therapies in the future. And they can see the future of CRISPR is very exciting. It's expanding, growing area. And so, that agreement was in place already when the baby KJ case came to our attention. And so, what we're hoping to do with Danaher is again, work with them and their scientists to continue to ask, how can we reduce the cost of these therapies by reducing the cost of the molecules that are necessary, how to make them efficiently. We already, it's very interesting, Fyodor Urnov has toured their plant in North Dakota recently, and he found in talking to their engineers, there are a number of things that we can already see will be possible to do that are going to make the process of manufacturing these molecules faster and cheaper by a lot.Eric Topol (19:28):Wow.Jennifer Doudna (19:28):So it's a win-win for everybody. And so, we're really excited to do that in the context of this new Center.Eric Topol (19:36):Oh, that's phenomenal because some of these disorders you don't have that much time to work with before they could be brain or organ or vital tissue damage. So that's great to hear that. What you built here is the significance of it can't be under emphasized, I'll say because we have this May report of baby KJ, which could have been a one-off and it could have been years before we saw another cure of an ultra-rare disorder. And what you're doing here is insurance against that. You're going to have many more cracks at this. And I think this is the excitement about having a new dedicated Center. So just in closing, maybe some remarks from you Priscilla.Priscilla Chan (20:24):I just want to emphasize one point that's really exciting as we talk about these ultra-rare cases that they're often like one in a million. All these learnings actually help maximize the impact of lots of research across the sector that impacts actually everyone's health. And so, our learnings here from these patients that have very significant presentations that really can stand to benefit from any treatment is hopefully paving the way for many, many more of us to be able to live healthier, higher quality lives through basic science.Eric Topol (21:13):And over to you, Jennifer.Jennifer Doudna (21:15):Couldn't agree more. It's a really interesting moment. I think what we hope we are, is we're at sort of an inflection point where, as I mentioned earlier, all the pieces are in place to do this kind of therapeutic and we just need a team that will focus on doing it and pulling it together. And also learning from that process so that as Priscilla just said, we are ultimately able to use the same strategy for other diseases and potentially for diseases that affect lots of people. So it's exciting.Eric Topol (21:46):For sure. Now, if I could just sum up, this is now a decade past the origination of your work of CRISPR and how already at the first decade culminated in sickle cell disease treatment and β-thalassemia. Now we're into the second decade of CRISPR. And look what we've seen, something that was unimaginable until it actually happened and was reported just a little over a month ago. Now going back to Priscilla's point, we're talking about thousands of different rare Mendelian genomic disorders, thousands of them. And if you add them all up of rare diseases, we're talking about hundreds of millions of people affected around the world. So this is a foray into something much bigger, no less the fact that some of these rare mutations are shared by common diseases and approaches. So this really big stuff, congratulations to both of you and your organizations, the Innovative Genomics Institute and the Chan Zuckerberg Initiative for taking this on. We'll be following it with very deep interest, thank you.****************************************************Thanks for listening, reading and subscribing to Ground Truths.If you found this interesting PLEASE share it!That makes the work involved in putting these together especially worthwhile.Thanks to Scripps Research, and my producer, Jessica Nguyen, and Sinjun Balabanoff for video/audio support.All content on Ground Truths—its newsletters, analyses, and podcasts, are free, open-access.Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don't hesitate to post comments and give me feedback. Let me know topics that you would like to see covered.Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. Get full access to Ground Truths at erictopol.substack.com/subscribe

How can today's pediatricians truly connect with time-crunched, digitally-savvy parents and build lasting loyalty? In this episode, Rob Klein shares key findings from his 2025 National Consumer Insights Study (NCIS) – Peds Edition, revealing what's shaping parental choices, the decline in trust in healthcare, and how organizations can reinvent care delivery, starting with pediatric and maternity services.

Reference: Arnold CG, et al. Performance of individual criteria of the Pediatric Emergency Care Applied Research Network (PECARN) intraabdominal injury prediction rule. Acad Emerg Med. Jan 2025 Date: May 7, 2025 Guest Skeptic : Dr. Sandi Angus is a Paediatric and Adult Emergency Medicine Registrar in the Shrewsbury and Telford Hospital NHS Trust. She is passionate about […] The post SGEM #479: Light Em Up Up Up (CT) or Not for Pediatric Blunt Abdominal Trauma? first appeared on The Skeptics Guide to Emergency Medicine.

This week Dr. Nadine Choueiter of Mount Sinai hosts a special episode of Pediheart: Pediatric Cardiology Today in which we speak with emeritus Professor of Pediatrics at the University of Toronto, Dr. Brian McCrindle about his career and life. How did he develop a love of pediatric cardiology? Who were some of his early mentors? How did he develop the international Kawasaki Disease Registry and how has he cultivated it despite minimal funding? How did he develop an interest in preventive cardiology? How can a young person make their clinical work also their academic work? Dr. McCrindle also shares some insights into navigating a successful life as well as retirement. This is a rare opportunity to be inspired by one of the great pediatric cardovascular researchers of the past 3 decades. 

Expanding into sleep dentistry can bring a new level of fulfillment to your career and positively impact your patients' lives. Our guest today is Dr. Jacqueline Patterson, a general dentist and Orofacial Myofunctional Therapist with over 15 years of experience. She believes that early assessment and intervention in children suffering from airway issues can non-invasively improve both their dental and overall health, with benefits that will last a lifetime. Dr Patterson, thanks for joining us. Thanks to our episode sponsors: VOCO America - https://www.voco.dental/us/ Centrix Dental - https://www.centrixdental.com/ GUM - https://www.sunstargum.com/us-en/

In this episode, we visit Bambino Gesù Children's Hospital in Rome to explore the pioneering pediatric brain tumor research being led by Maria Vinci, MD. Her team focuses on high-grade pediatric brain tumors including diffuse midline gliomas, with the goal of advancing more personalized and effective therapies for children around the world. We tour three key research labs that play a central role in their work: the patient-derived model lab, the high-content imaging lab, and the Hyperion lab, which uses advanced single-cell spatial proteomics to better understand the tumor microenvironment. Together, these technologies allow Dr. Vinci's team to investigate how these aggressive tumors develop and respond to potential treatments. This episode provides a rare behind-the-scenes look at how leading scientists and clinicians in Rome are pushing the boundaries of pediatric neuro-oncology and working to bring new hope to families facing devastating diagnoses. This episode is intended for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for guidance specific to your health or treatment plan.

What are the pediatric support options for NY families with special needs kids? It's a question asked by many - and carers like Amelia Home Care ((929) 333-3955) are looking to make sure it's easy to find answers.Visit https://ameliahomecareny.com/pediatric-home-care/ for info. Amelia Home Care City: Brooklyn Address: 3007 Ocean Parkway Website: https://www.ameliahomecareny.com/

Earn 0.1 ASHA CEUs for this episode: https://www.speechtherapypd.com/courses/valuing-pediatric-vfssIn this episode, Michelle interviews Anais Villaluna, SLPD, MS, CCC-SLP, BCS-S, CLC, a trilingual speech-language pathologist, to discuss best practices and critical considerations for pediatric Video Fluoroscopic Swallow Studies (VFSS). Anais, who has just completed her SLPD and is already embarking on her PhD journey, shares insights from recent research, including the importance of radiographic settings, hidden technological considerations that can impact the outcome, the value of interdisciplinary collaboration, and how to support the little ones and their caregivers through the VFSS process. If you're not familiar with conducting VFSS, or even if you're a seasoned veteran, this episode will have nuggets of EBP for everyone!

In this podcast, JPEN Editor-in-Chief Dr. Kenneth Christopher, interviews Niklas Tappauf PhD Candidate in Experimental Medicine at The University of British Columbia. Niklas Tappauf's research is on pediatric health and biomarker development with a specific focus on the microbiome. Niklas Tappauf is first author of the research article “Multiomics profiling and parenteral nutrition weaning in pediatric patients with intestinal failure: A longitudinal cohort study”. Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US May 2025

Moderator: James P. Rathmell, M.D. Participants: Paul Lee-Archer and Clyde Matava, M.B.Ch.B., M.Med., M.H.S.C. Articles Discussed: Development of the Pediatric Scale for Quality of Recovery (PedSQoR) Measuring what Matters - the Pediatric Scale for Quality of Recovery

If Chiropractic is unsafe, you would imagine that a Chiropractor's malpractice insurance would reflect that. Let's take a look…

Navigating the complex landscape of patient safety requires vigilance, knowledge, and adaptability. Today's episode takes us on a journey through two critical safety concerns that exemplify the challenges anesthesiologists face in diverse clinical settings.We begin with an eye-opening exploration of cosmetic surgery safety in Colombia, which has emerged as a top global destination for aesthetic procedures. Despite performing nearly 500,000 cosmetic surgeries annually, Colombia faces alarming safety statistics—mortality rates potentially ten times higher than global averages for anesthesia-related deaths. This stark disparity highlights how regulatory gaps, substandard facilities, and inadequate patient selection can create perfect storms for adverse outcomes. The discussion illuminates how anesthesiologists can serve as safety champions by implementing rigorous standards and protocols.The conversation then pivots to a surprisingly common yet overlooked danger in pediatric anesthesia: the administration of oxymetazoline. What seems like a routine medication becomes hazardous when delivery systems designed for upright, conscious patients are used on supine, anesthetized children. Through practical demonstrations and creative problem-solving, we uncover how simple modifications to delivery methods—specifically using atomizers with precisely filled syringes—can prevent potentially dangerous overdoses and create standardized, position-independent dosing.Both topics underscore a central theme: anesthesia safety demands thoughtful adaptation of standards to fit unique circumstances. Whether dealing with international variations in practice or the specialized needs of pediatric patients, the commitment to "no one shall be harmed by anesthesia care" requires constant vigilance and innovation. We'd love to hear your experiences with similar challenges—have you encountered safety variations in different practice settings, or developed creative solutions to common problems? Visit APSF.org to explore our resources and join the conversation about advancing anesthesia patient safety worldwide.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/261-patient-safety-challenges-from-global-cosmetic-tourism-to-pediatric-medication-dosing/© 2025, The Anesthesia Patient Safety Foundation

Hospital at home programs have been around for years but gained popularity during the pandemic. While HaH has long been tailored for adults—mainly seniors—some hospitals are experimenting with programs that allow other patients to receive acute care at home, including Atrium Health Levine Children's Hospital which piloted a first-in-the-nation hospital at home program. Stefanie Reed, DO, who serves as the Medical Director of the program, joins host J. Carlisle Larsen to talk more about what they've learned since launching the program and the outcomes of the pilot. Hosted on Acast. See acast.com/privacy for more information.

ARFID and pediatric feeding disorders take center stage this week on The Untethered Podcast.Hallie welcomes pediatric feeding expert Melanie Potock, MA, CCC-SLP, to discuss the connection between ARFID (Avoidant Restrictive Food Intake Disorder), pediatric feeding disorders (PFD), and childhood anxiety.Melanie, a licensed speech-language pathologist and internationally recognized author, breaks down how anxiety plays a central role in many feeding challenges—and how understanding this connection can help families and professionals create meaningful progress.Whether you're a parent navigating extreme picky eating or a professional working with feeding clients, this episode offers practical, compassionate strategies to reduce anxiety, build trust, and promote lasting change.If this episode resonates with you, take a screenshot while you're listening, post it to your Instagram Stories, and tag Hallie @halliebulkin and Melanie @mymunchbug_melaniepotockIn this episode, you'll learn:✔️ What differentiates picky eating from ARFID and PFD✔️ How anxiety influences feeding behavior and progress✔️ Ways to reduce anxiety for both children and parents✔️ Why parent coaching is essential in feeding therapy✔️ How autism spectrum disorder intersects with feeding challenges✔️ The power of a transdisciplinary treatment model✔️ Tools and strategies for making mealtimes less stressfulWhether you're a parent, therapist, or educator, this episode provides a roadmap to better understanding and supporting children with complex feeding needs.LINKSGet to know Melanie Potock on Instagram: https://www.instagram.com/mymunchbug_melaniepotock/Check out her website: https://mymunchbug.com/Be part of our Myo Fam! Join us inside The Myo Membership: www.themyomembership.comBecome a Certified Myofunctional Therapist™ (CMT®). Enroll here: www.themyomethod.comReady to turn your "myo eyes" on? Join our webinar: https://www.feedthepeds.com/myo-webinarDownload a Free F.A.S.T. Myo Screening Packet Here: FastMyoScreening.comFind a myofunctional therapist: www.themyodirectory.comConnect with Hallie on Instagram, Facebook & LinkedINHaven't left a review yet? Click here and thank you, as always, for being a listener! Want to watch more of the episode? Click here Hosted on Acast. See acast.com/privacy for more information.

A record high 7 million U.S. children have received an ADHD diagnosis, according to the Centers for Disease Control and Prevention. But journalist Paul Tough wonders if we're thinking about pediatric ADHD all wrong. For a recent New York Times Magazine feature, Tough spent a year talking to leading researchers who now say that standard treatments like Ritalin only help children behave better, not learn better – and even that effect wears off completely over time. We talk to Tough about why he says we need to reconceptualize diagnosis and treatment of ADHD. Guests: Paul Tough, contributing writer, New York Times Magazine Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we speak with congenital heart surgeon T. Konrad Rajab of Arkansas Children's Hospital about a recent report he co-authored on piglet experiments on partial heart transplantation. How did transplanted heart valves grow in comparison to standard homografts and how did the valvular function differ with time? Is there a minimum dose of immunosuppresion that can protect these valves and can this dose be lower than full heart transplantation immunosuppresion therapy? Is partial heart transplantation considered a potential life-long approach to valve replacement or mostly something used to allow for growth of valves during childhood? What do we know about the world's limited experience in humans of this approach? Dr. Rajab shares the answers this week in an exciting 'sci-fi' episode. The future is now.https://doi.org/10.1016/j.jacbts.2024.10.015

Send us a textOne of my most favorite things to do is laugh. Seriously. There are some things you cannot do with others. I could name a few but one thing you don't do is laugh at a funeral. Don't do that. BUT! LAUGH your butt off with anyone YOU SO CHOOSE, anywhere else! When you do, appropriately, you create this moment with others that disperses quickly!  In that moment, you produce this burst of brightness. Either within yourself, or even more effective, with others! Today we welcome an amazing Comedian that recently graced our Nola's own, Dirty Coast Apparel shop to record her very first NATIONAL Comedy show!  Jessica Michelle Singleton joined me to not only talk about her freaking hilarious and brand new comedy special, BUT her driving force to be who and where she is right now. Not sure if yall know this or not but or FEMALES of our country are outnumbered in this amazing profession and I will go out there and say probably in most professions! This gal is FUNNY you guys. Please listen to this and show her some love by watching this insanely comedy special taped at Dirty Cost!Find all of her laughter at: www.punchup.live________________________________________________________________________________________Then later, We welcome back our dear friends from Ochsner Children's Hospital to talk about Pediatric and seasonal things to keep our eyes focused on when we have little minions running around night and day. It is relevant, needed and I am here for ALL OF IT! Today, We talk to Dr. Nakita Patel Ochsner Pediatrician about all things SUMMER!  Dr. Patel has such a way to break down the things we need to remember. Check it out now! Find ANYTHING you need within your family at www.ochsnerhealth.orgThank you to our family of amazing sponsors! Ochsner Hospital for ChildrenWww.ochsner.orgRouses MarkersWww.rousesmarkets.comSandpiper VacationsWww..sandpipervacations.comCafe Du Monde www.shop.cafedumonde.com The Law Firm of Forrest Cressy & James Www.forrestcressyjames.comComfort Cases Www.comfortcases.orgNew Orleans Ice Cream CompanyWww.neworleansicecream.comERA TOP REALTY: Pamela BreauxAudubon Institute www.auduboninstitute.orgUrban South Brewery www.urbansouthbrewery.com

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Linda Brubaker, MD, Deputy Editor of JAMA, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from June 21-27, 2025.

This episode of The Mile High Podcast features a dynamic and purpose-driven conversation with Dr. Ian Shtulman, a second-generation chiropractor, Diplomate in Chiropractic Pediatrics, and passionate ICPA instructor. Dr. Shtulman is a leading voice in perinatal and pediatric chiropractic. With clinical depth, real-world experience, and a talent for breaking down complex ideas into simple, powerful truths, he delivers real tools and perspectives you can apply right now.

In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Jean Holowach-Thurston. 

In this episode of Thal Pals, NinaMaria speaks with nurse practitioner Melony Avella-Howell about the challenges and solutions in transitioning from pediatric to adult care for patients with chronic illnesses like thalassemia and sickle cell disease. They discuss the importance of community support groups, tailored transition programs, and the roles of providers in helping young adults navigate this vulnerable period. Melony shares insights from her experience in hematology, emphasizing the need for individualized care plans and proactive patient advocacy. Together, they highlight the significance of addressing both medical and life challenges to ensure comprehensive care.   SHOW DESCRIPTION Thal Pals: The Alpha Beta Revolution Podcast is intended for patients, caregivers, providers, and the greater community of people who are impacted by thalassemia. Each episode strives to provide listeners with critical education, the latest scientific updates, and voices from the thalassemia community. Learn more about thalassemia by visiting RethinkThalassemia.com. Join an inclusive community and build connections with other hemolytic anemia allies by following @AllyVoicesRising on Instagram. Thal Pals is sponsored by Agios Pharmaceuticals Inc. Visit Agios.com to learn more.   This podcast is intended for informational and educational purposes only and is not intended as medical advice. Please speak with your healthcare professional before making any treatment decisions.    TRANSPARENCY STATEMENT  Thal Pals: The Alpha Beta Revolution Podcast is made possible by Agios Pharmaceuticals Inc. Visit Agios.com to learn more. The following Agios-supported programs are intended for informational and educational purposes only and are not intended as medical advice. Please speak with your healthcare professional before making any treatment decisions. Host and guest featured in this episode have been compensated for their time.

Navigating A Stellar Career in Pediatric Dermatology: Dr. Ilona FriedenIn this episode of The Girl Doc Survival Guide, Dr. Ilona Frieden, a distinguished leader in pediatric dermatology, shares her journey and insights. Dr. Frieden discusses her personal background, the challenges she faced growing up in California, and her unexpected path into medicine. She underscores the importance of balancing career aspirations with personal well-being and family, talking about her own experiences with social activism, feminism, and motherhood. Dr. Frieden also highlights the significance of finding meaning and community in one's work, her pragmatic approach to problem-solving, and the vital role of humility and collaboration in medical practice. This episode offers valuable lessons on work-life balance, career development, and the evolving nature of professional fulfillment.00:00 Introduction and Guest Background01:27 Personal Anecdotes and Early Life03:13 Career Journey and Achievements05:13 Work-Life Balance and Parenting09:55 Mentorship and Professional Insights16:37 Reflections on Medicine and Legacy23:28 Final Thoughts and Gratitude

With the Wind with Dr. Paul – Show 178: Pediatric Perspectives: Allopathic Medicine Misses Root Causes with Ken Stoller M.D Presenters: Dr. Paul Thomas and Dr. Ken Stoller Length: Approx. 42 minutes ________________________________________ Summary: In this revealing episode of Pediatric Perspectives, Dr. Paul welcomes Dr. Ken Stoller, a fellow pediatrician and outspoken critic of modern allopathic medicine. Drawing from decades of experience, Dr. Stoller unpacks why he believes mainstream healthcare fails to address the root causes of disease—and how this system has evolved into what he calls a “death cult.” From questioning vaccine safety and the lack of informed consent to discussing hyperbaric oxygen therapy and dietary interventions, Dr. Stoller provides a compelling case for rethinking medicine as we know it. Dr. Paul and Dr. Stoller also reflect on their personal awakenings and professional sacrifices made in pursuit of truth and health advocacy. The conversation ends with practical advice for parents navigating today's toxic health landscape: prioritize nutrition, reject harmful interventions, and take full responsibility for your family's health. ________________________________________ Key Points: • How allopathic medicine avoids root causes and prioritizes symptom suppression • The troubling history and lack of informed consent behind the hepatitis B vaccine • Hyperbaric oxygen therapy and its overlooked role in treating brain-related conditions • Dietary dangers including seed oils, processed foods, and environmental toxins • Vaccine-induced encephalopathy and the mislabeling of autism • Strategies parents can adopt to protect their children's health, including diet and avoiding unnecessary pediatric interventions ________________________________________ Resources: • Incurable Me by Dr. Ken Stoller: https://www.amazon.com/Incurable-Me-Research-Clinical-Practice/dp/1536669458 • Pro Oxygen | Dr. Stoller's Hyperbaric Practice: http://stollerhbot.com/ ________________________________________ Conclusion: Dr. Ken Stoller's journey from mainstream pediatrician to outspoken advocate for medical reform is both courageous and eye-opening. This episode challenges deeply held assumptions about vaccines, healthcare institutions, and chronic disease—and encourages parents to think critically and act independently in pursuit of true wellness. ________________________________________ Call to Action: Don't miss this powerful discussion. Watch the full episode of

With 20 years of experience spanning top pediatric hospitals, cutting-edge research, and digital health leadership, Sharmeen brings unmatched insight into what it takes to personalize care at scale—especially for our smallest, most complex patients. From gene-guided dosing to scaling PGx programs in hospital systems, we discuss: Why a "one-size-fits-all" model doesn't work in pediatrics How PGx can reduce the "trial-and-error" of ADHD, anxiety, and pain meds What it means to operationalize precision medicine in hospitals and clinics Her career journey—from the bedside to boardrooms and biotech The intersection of technology, pharmacy, and compassionate care Plus, don't miss Sharmeen's thoughts on: The future of pediatric PGx What excites her about working with organizations like CPIC, STRIPE, and PPA

In this episode, Jerry Kennedy explores what it takes to build a referral-based chiropractic practice. While many chiropractors say they want more word-of-mouth referrals, most don't have a clear strategy in place to make it happen. Jerry breaks down the keys to increasing referrals, explains the different types of referral sources, discusses why people refer (and why they don't), and offers practical tips on building stronger community and professional connections. Whether you're just getting started or you're ready to reduce your dependency on paid ads, this episode is packed with clarity and direction. Topics Covered The Value of a Referral-Based Practice Why word-of-mouth marketing is still the most stable and reliable form of growth The instability of modern advertising platforms compared to long-term relationships Why referrals are the “golden goose” for chiropractors Keys to Getting More Referrals Jerry outlines core principles every chiropractor should focus on: Make referrals normal in your office culture Be specific about who you help Make referring as easy as possible Deliver excellent, trustworthy care Build and maintain strong relationships Have a long-term plan and stay consistent Be the kind of person who also gives reviews and referrals Types of Referrals Chiropractors Can Get It's not just about patients sending in their friends. Jerry explains: Patient Referrals – Direct recommendations from satisfied patients Small Business & Professional Referrals – From people who may never become patients but trust you Medical Referrals – From MDs, PTs, massage therapists, and other healthcare providers Community Referrals – From people who only know your reputation, not you personally Digital Referrals – Reviews, shares, and online recommendations that create social proof Understanding Why People Refer They've had a positive or unexpected experience They like and trust you You asked them to refer They're returning a favor (reciprocity) They perceive you as an authority You've made it easy and clear who you want to help They've built a relationship with you over time The Truth About Referral Expectations Not everyone refers—and that's normal Trying to force referrals from everyone leads to disappointment The goal is to increase your referral percentage, not make it universal Focus on clarity, consistency, and communication Tips for Building Non-Patient Referral Relationships Understand that non-patient referrals take longer Start with people you already know Ask for introductions instead of cold outreach Get involved in community and networking groups (BNI, chambers, local events) Focus on solving problems, especially for busy professionals Stay in touch without being annoying Know when to walk away from dead-end connections Who Should You Be Networking With? Your neighbors: anyone near your office, regardless of profession People aligned with your niche: Pediatric chiropractors should connect with mom groups and birth professionals Sports chiropractors should connect with coaches, gyms, and athletes People in the communities where you want to be known and respected Final Thoughts A referral-based practice doesn't happen by accident. It requires a deliberate, ongoing effort to build relationships, communicate clearly, and provide consistent value. While it won't produce instant results, over time it becomes one of the most stable and rewarding ways to grow a chiropractic practice.   Want Help Growing Your Practice? Jerry offers business coaching, website design, SEO, and Google Ads services specifically for chiropractors. If you're ready for less stress and more momentum, visit RocketChiro.com. Free Website/SEO Review: https://rocketchiro.com/chiropractic-practice-assessment Best chiropractic websites: https://rocketchiro.com/best-chiropractic-websites Chiropractic SEO: https://rocketchiro.com/chiropractic-seo Coaching for Chiropractors: https://rocketchiro.com/join

Learn about the specialty of pediatric palliative care and how one doctor has benefitted from his relationship with his seriously ill patients. My guest Dr. Bob Macauley is one of only a few hundred pediatricians in the U.S. specializing in palliative care for children with life-threatening illness. Uniquely Dr. Macauley attended both divinity school and… Continue reading Ep. 506 Pediatric Palliative Care and the Remarkable Children it Serves with Bob Macauley MD

Not all sports dietitians are created equal—especially when it comes to working with young, developing gymnasts. In this episode, I'm breaking down why your gymnast needs a pediatric/adolescent sports dietitian, not just any sports RD who's used to fueling adult athletes. The nutritional needs of gymnasts are not the same as grown adults like college or professional athletes. Your gymnast is still growing, developing, and navigating puberty—all while training like an elite athlete. That's a unique combination that deserves a specialized approach.As a parent, you want to work with someone who not only understands fueling for performance, but also knows how to support long-term health, hormonal development, injury prevention, and medical nuances like growth delays, allergies, or GI issues—all of which are way more common in this sport than most people realize. That's what sets a pediatric/adolescent sports dietitian apart.We're doing all the sports nutrition things—helping with fueling before, during, and after practice and maximizing recovery. But there's so much more to layer onto that. We're also doing what's called medical nutrition therapy, making sure these gymnasts are growing and developing on time. In this episode you'll learn about: Why young gymnasts aren't just “small adults” and can't be treated as such nutritionally even if they're athletesThe difference between a general sports dietitian and a pediatric/adolescent sports dietitian and all the training requiredWhy nutrition for gymnasts must be individualized and age-appropriate and can't be generalized  Links & Resources    The Balanced Gymnast® Program for level 5-10 female gymnasts Episode 129: Why gymnast growth charts are so important to success in the sportEpisode 112: Is your “tiny gymnast” actually underfueled, or growing normally for them?Connect with Christina on Instagram @the.gymnast.nutritionist or christinaandersonrdn.com

This World Shared Practice Forum reviews the Global PARITY study, a comprehensive research initiative aimed at understanding and addressing pediatric critical illness in resource-constrained settings. The discussion highlights the methodology, challenges, and key findings of the study, emphasizing the high prevalence of critical illnesses such as pneumonia, sepsis, and malaria among children in low socio-demographic index regions. The authors stress the importance of basic critical care interventions and the need for global health equity, advocating for the integration of critical care into health systems worldwide. LEARNING OBJECTIVES - Understand the methodology and challenges of conducting the Global Parity Study in resource-constrained settings. - Identify the most common pediatric critical illnesses and their prevalence in low socio-economic regions. - Recognize the importance of basic critical care interventions in improving health outcomes for critically ill children. - Appreciate the role of global health equity and the need for integrating critical care into health systems. - Explore the potential impact of research findings on policy decisions and resource allocation in healthcare. AUTHORS Teresa Kortz, MD, MS, PhD Associate Professor of Clinical Pediatrics University of California, San Francisco Adrian Holloway, MD Associate Professor Pediatrics University of Maryland School of Medicine, Department of Pediatrics Traci Wolbrink, MD, MPH‌ Senior Associate in Critical Care Medicine Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Associate Professor of Anesthesia Harvard Medical School DATE Initial publication date: June 23, 2025. ARTICLE REFERENCED Kortz TB, Holloway A, Agulnik A, et al. Prevalence, aetiology, and hospital outcomes of paediatric acute critical illness in resource-constrained settings (Global PARITY): a multicentre, international, point prevalence and prospective cohort study. Lancet Glob Health. 2025;13(2):e212-e221. doi:10.1016/S2214-109X(24)00450-9 TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/sf6v5frcmb9j5pt3vrrss67/Kortz__Holloway_PWSP_June_2025_Transcript Please visit: www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open-access, thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu Please note: OPENPediatrics does not support or control any related videos in the sidebar; these are placed by YouTube. We apologize for any inconvenience this may cause. CITATION Kortz TB, Holloway A, Wolbrink TA. Global PARITY Study: Pediatric Critical Illness Insights. 06/2025. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/global-parity-study-pediatric-critical-illness-insights-by-t-kortz-a-holloway-openpediatrics.

This engaging and informative webinar explores the role of OX40 and OX40L in pediatric dermatology. OX40: Innovative Insights and Therapeutic Potential in Pediatric Dermatology brings together experts in the field to discuss emerging research, mechanisms of action, and the implications of targeting the OX40 pathway for treating chronic inflammatory skin diseases in children. To view the video version of this webinar, please click here. Disclosures:Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, Dermavant, Eli Lilly, Forte, Galderma, Incyte Corporation, Janssen, Johnson & Johnson, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Target RWE, T-Rex, and UCB.Eric Simpson, MD reports personal fees from AbbVie, Aclaris Therapeutics, Amgen, Arcutis, Astria Therapeutics, Attovia Therapeutics, Inc., Bambusa Therapeutics Inc., Castle, CorEvitas, Dermira, Eli Lilly, Evomunne, FIDE, Impetus Healthcare, Incyte, Innovaderm Reche/ Indero, Inmagene Biopharmaceuticals, Janssen, LectureLinx (LLX), Leo, NUMAB Therapeutics AG, Pfizer, Recludix Pharma, Regeneron, Roche Products Ltd, Sanofi-Genzyme, SITRYX TherapeuticsEric Simpson, MD reports grants (or serves as Principal investigator role) for AbbVie, Acrotech, Amgen, Arcutis, ASLAN, Castle, Dermavant, CorEvitas, Dermira, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, Target, VeriSkinJoy Wan, MD Sun Pharmaceuticals - consulting (DMC), Astria Therapeutics - consulting (ad board), Galderma - fellowship funding (paid to Johns Hopkins)

Ep 325: Introducing Solid Foods with Pediatric Feeding Experts Cinthia Scott, RD, IBCLC & Catherine Callahan, MS, CCC-SLP, CLCThis week on The Untethered Podcast, we welcome two incredible pediatric feeding specialists: Catherine Callahan & Cinthia Scott. Catherine is a speech-language pathologist and pediatric feeding therapist, while Cinthia is a pediatric registered dietitian and lactation consultant. Together, they discuss their new book, Baby Leads the Way, which provides an evidence-based guide to starting solid foods. They share valuable insights on recognizing readiness for solids, the benefits of baby-led feeding, early allergen introduction, and maintaining responsive feeding practices that encourage intuitive eating in children. If this episode has resonated with you in some way, take a screenshot of you listening, post it to your Instagram Stories, and tag Hallie @halliebulkinIn this episode, you'll hear:✔️ How to know when your baby is ready for solids✔️ The benefits and basics of baby-led weaning✔️ Introducing allergens safely and early✔️ Maintaining responsive feeding to foster intuitive eating✔️ Handling choking concerns with confidence✔️ Tips to prevent picky eating✔️ Creating varied, nutritious meals for the whole familyWhether you're a parent or professional, this episode is packed with practical strategies to support your baby's feeding journey with confidence and joy!LINKSGet to know Catherine Callahan & Cinthia Scott on Instagram here and here.Check out her website: https://thebabydietitian.com/about/ and https://www.chikidsfeeding.com/Be part of our Myo Fam! Join us inside The Myo Membership: www.themyomembership.comBecome a Certified Myofunctional Therapist™ (CMT®). Enroll here: www.themyomethod.comReady to turn your "myo eyes" on? Join our webinar: https://www.feedthepeds.com/myo-webinarDownload a Free F.A.S.T. Myo Screening Packet Here: FastMyoScreening.comFind a myofunctional therapist: www.themyodirectory.comConnect with Hallie on Instagram, Facebook & LinkedINHaven't left a review yet? Click here and thank you, as always, for being a listener! Want to watch more of the episode? Click here Hosted on Acast. See acast.com/privacy for more information.

There is a lot of mis and dis information out there around gender affirming care for youth. This is both fueled by and leads to a general misunderstand about the basic ethical considerations present similar to other aspects of clinical care. On this episode of A Question of Ethics, Dr. Wolfe talks with the head of Children's Gender Clinic to discuss the ethical considerations around gender affirming care for youth.

Pediatric nurse and lactation consultant Angie Howell shares her profound journey of experiencing a medical miracle with her eighth child, Jade. Amidst personal turmoil and uncertainty, Angie recounts the miraculous healing of Jade through a prayer gathering led by her cousin Rich and his Christian biker group. The episode highlights Angie's initial struggle with faith, the transformative power of prayer, and the eventual realization that Jesus was with her throughout her trials. Angie also discusses her nursing career, the founding of her home health agency for children with disabilities, and hints at a potential film adaptation of her powerful story. The episode concludes with a heartfelt prayer.  00:00 A Miraculous Encounter with Jesus 00:52 Introducing Angie Howell 01:51 Angie's Life Before the Miracle 02:55 The Rollercoaster of Emotions 05:42 Jade's Diagnosis and Struggles 12:33 A Divine Intervention 14:45 The Prayer Meeting 20:11 The Miraculous MRI Results 23:19 A Miracle in the Midst of Struggle 24:01 The Journey of Jade's Progress 27:13 Faith and Personal Growth 33:26 Jade's Miraculous Encounter 37:25 Current Life and Future Plans 42:33 Conclusion and Final Thoughts Angie's new book: Jewel of Heaven: https://a.co/d/963MWLT Angie's website: https://www.angiehowell.com/

Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode Jennifer Schoch, MD, FAAD, FAAP, discusses updated guidelines for the diagnosis and treatment of atopic dermatitis or eczema. Hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Esli Osmanlliu, MD, and medical student Nik Jaiswal about the accuracy of large language models in pediatric and adult medicine. For resources go to aap.org/podcast.

Pediatric dietician and foster mama Madison Tyler joins me on this week's episode to share some signs that your foster or adoptive kiddo might be struggling with trauma-related food issues and how to solve them. If you'd like to learn more from Madison, you can follow her on Instagram here: https://www.instagram.com/nourishwithconnection/

Every other week I'm republishing one of my most popular or impactful episodes and adding an update, new insight, or context that will help you benefit from it even more. This week I'm highlighting Episode 116, which is all about pediatric pharmacology. When you understand these key foundation concepts, the whole subject of pharm gets a whole lot easier. Enjoy! As cute and adorable as they are, kids are not just tiny adults. Especially when it comes to pharmacology. The way kids absorb, distribute, metabolize and excrete drugs varies greatly, making pediatric pharmacology a truly unique subject.  If you're heading into your pediatric rotation or starting out as a new pediatric RN, then pop in those earbuds. I'll talk you through the key things you need to know to utilize medications safely in this very special and vulnerable population.  ___________________ ⁠Full Transcript⁠ - Read the article and view references ⁠FREE CLASS⁠ - If all you've heard are nursing school horror stories, then you need this class! Join me in this on-demand session where I dispel all those nursing school myths and show you that YES...you can thrive in nursing school without it taking over your life! ⁠Dosage Calculations Guide⁠ - Kick math anxiety to the curb and learn the basics of how to set up and perform dosage calculations using dimensional analysis with this FREE guide. Includes 10 free practice questions! ⁠Pharmacology Success Pack⁠ - Want to get a head start on pharmacology? Download the FREE Pharmacology Success Pack.  ⁠Fast Pharmacology⁠ - Learn pharmacology concepts in 5 minutes or less in this audio based program. Perfect for on-the-go review! ⁠Straight A Nursing App⁠ - Study on-the-go with the Straight A Nursing app! Review more than 5,000 flashcards covering a wide range of subjects including Fundamentals, Pediatrics, Med Surg, Mental Health, Maternal Newborn, and more! Available for free in the Apple App Store and Google Play Store.